Biotricity (NASDAQ:BTCY) Trading 6.9% Higher – Time to Buy?

Biotricity, Inc. (NASDAQ:BTCY) shares traded up 6.9% during mid-day trading on Thursday . The company traded as high as $0.33 and last traded at $0.31. 104,856 shares were traded during mid-day trading, an increase of 37% from the average session volume of 76,434 shares. The stock had previously closed at $0.29.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a “neutral” rating on shares of Biotricity in a research report on Monday, November 18th.

Biotricity Stock Performance

The company’s fifty day simple moving average is $0.32 and its two-hundred day simple moving average is $0.46. The company has a market capitalization of $7.61 million, a price-to-earnings ratio of -0.23 and a beta of 1.14.

Institutional Trading of Biotricity

A hedge fund recently bought a new stake in Biotricity stock. AE Wealth Management LLC purchased a new stake in Biotricity, Inc. (NASDAQ:BTCY) in the second quarter, according to its most recent filing with the SEC. The fund purchased 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned about 0.45% of Biotricity at the end of the most recent quarter. Institutional investors and hedge funds own 3.89% of the company’s stock.

About Biotricity

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.